Home » Newsletters » BioWorld

BioWorld

June 17, 2003

View Archived Issues

Celltech, BMS Stop Development Of NSCLC Product After Phase II

Arizona Scientists Probe Pros, Cons Of Aspirin Mixed With Other Items To Avoid Recurrence Of Malignancy

Deltagen Considers Bankruptcy; Lease Deal Ending, Officers Quit

Correction

Cytogen Regains Rights To Berlex's Cancer Pain Product

Other News To Note

ICOS Planning To Raise $250M Through Private Sale Of Notes

ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today) Read More